Interestingly, Gal-3 expression is upregulated in both, suggesting it may contribute to the increased inflammation seen in obesity and in old age and that blocking Gal-3 may be a viable therapeutic target [3,11]. Here, LGALS3 is linked to obesity due to melanocortin 4 receptor deficiency.